Condition: Candida · Sponsor: University Hospital, Toulouse
The aim of this study is to evaluate the implementation of a new technique for invasive candidiasis diagnosis by PCR. The main objective will be to evaluate the effect of this strategy on the time required to obtain results in patients from intensive care units with suspected systemic invasive candidiasis. This PCR method could allow an antifungal switch to be made earlier, limiting the appearance of resistance and reducing the cost of antifungals for healthcare facilities.
This description comes directly from the study's public registry record.
Pamela CHAUVIN · 05 67 69 04 09 · chauvin.p@chu-toulouse.fr
Xavier IRIART · 05 67 69 04 99 · iriart.x@chu-toulouse.fr
Always discuss trial participation with your own doctor first.
| Uh Toulouse | Toulouse, Occitanie, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04874441